Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Ovarian Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Retinoblastoma 2Resectable Non-small Cell Lung Cancer 2Neoplasms 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Urinary Bladder Neoplasms 1Squamous-Cell Lung Cancer 1Sjogren's Syndrome 1Scleroderma, Systemic 1Retinal Neoplasms 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Psoriasis 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1Oropharyngeal Neoplasms 1Nonsquamous Non-small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1NSCLC 1Multiple Sclerosis 1

Interventions

Carboplatin 12Pemetrexed 8pembrolizumab 4Paclitaxel 4Cisplatin 4durvalumab 3Radiosurgery 3Gemcitabine 3selpercatinib 2pralsetinib 2osimertinib 2camrelizumab 2atezolizumab 2Docetaxel 2taletrectinib 1repotrectinib 1motexafin gadolinium 1exemestane 1entinostat 1ceralasertib 1cemiplimab 1belinostat 1belagenpumatucel L 1alectinib 1Vinorelbine 1Tyrosine Kinase Inhibitors 1TNFSF10 protein, human 1Radiotherapy 1Platinum Compounds 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Bronchogenic × Platinum Compounds × Clear all
NCT06623656 2026-04-21

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Weill Medical College of Cornell University

Phase 2 Recruiting
112 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡